AFLAVIS 1 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Dexamethasone phosphate, Dexamethasone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AFLAVIS 1 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec embout(s) polyéthylène haute densité (PEHD) siliconé(e)
- Marketing authorisation holder
- LABORATOIRES DOLIAGE DEVELOPPEMENT
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60833559CIP73017313CIP133400930173138Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEcollyre | 1,093 mg · 1 mL de solution | SA |
| PHOSPHATE DE DEXAMÉTHASONEcollyre | 1 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.